Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc.

CARM
Carisma Therapeutics, Inc.US flagOther OTC
0.01
USD
+0.00
- -
213,410.00Market Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
10
15
20
+ Sales & Services Revenue
- -
- -
10
15
20
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-10
-15
-20
- Operating Expenses
28
41
66
104
82
+ Selling, General & Admin
5
6
9
30
22
+ Research & Development
23
34
57
74
60
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-28
-41
-56
-89
-62
- Non-Operating (Income) Loss
- -
- -
5
-2
-2
+ Interest Expense, Net
- -
- -
3
-2
-2
+ Interest Expense
- -
- -
3
- -
- -
- Interest Income
- -
- -
- -
2
2
+ Other Non-Op (Income) Loss
- -
- -
2
- -
- -
Pretax Income
-28
-41
-61
-87
-60
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-28
-41
-61
-87
-60
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-28
-41
-61
-87
-60
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-28
-41
-61
-87
-60
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-28
-41
-61
-87
-60
EBIT
-28
-41
-56
-89
-62
EBITDA
-28
-40
-54
-86
-59
EBITDA Margin (%)
- -
- -
-551.85
-575.74
-299.64
EBITA
-28
-41
-56
-89
-62
Gross Margin (%)
- -
- -
100
100
100
Operating Margin (%)
- -
- -
-571.1
-594.75
-316.72
Profit Margin (%)
- -
- -
-622.6
-582.34
-308.05
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
2
3
3
Basic Weighted Avg Shares
40
40
40
34
41
Basic EPS, GAAP
-0.7
-1.01
-1.52
-2.59
-1.46
Basic EPS from Cont Ops
-0.7
-1.01
-1.52
-2.59
-1.46
Diluted Weighted Avg Shares
40
40
40
34
41
Diluted EPS, GAAP
-0.7
-1.01
-1.52
-2.59
-1.46
Diluted EPS from Cont Ops
-0.7
-1.01
-1.52
-2.59
-1.46

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
53
30
55
80
24
+ Cash, Cash Equivalents & STI
52
29
52
78
18
+ Cash & Cash Equivalents
52
29
24
78
18
+ ST Investments
- -
- -
28
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
3
3
6
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
5
6
18
9
7
+ Property, Plant & Equip, Net
5
6
13
9
6
+ Property, Plant & Equip
6
7
17
15
14
- Accumulated Depreciation
1
1
3
6
8
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
4
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
4
- -
- -
Total Assets
58
35
72
90
30
+ Payables & Accruals
5
7
9
8
5
+ Accounts Payable
3
2
2
4
2
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
4
8
5
3
+ ST Debt
1
1
5
2
2
+ ST Borrowings
- -
- -
- -
- -
- -
+ ST Finance Leases
1
1
5
2
2
+ Other ST Liabilities
- -
- -
6
5
10
+ Deferred Revenue
- -
- -
2
1
4
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
3
4
6
Total Current Liabilities
6
8
20
16
16
+ LT Debt
3
2
36
1
1
+ LT Borrowings
- -
- -
34
- -
- -
+ LT Finance Leases
3
2
2
1
1
+ Other LT Liabilities
- -
- -
160
46
42
+ Accrued Liabilities
- -
- -
45
45
41
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
115
1
- -
Total Noncurrent Liabilities
3
2
195
47
42
Total Liabilities
8
9
215
63
58
+ Preferred Equity and Hybrid Capital
92
108
- -
- -
- -
+ Share Capital & APIC
- -
1
1
272
278
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
1
272
278
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-56
-97
-158
-245
-306
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
36
12
-157
27
-28
+ Minority/Non Controlling Interest
14
14
14
- -
- -
Total Equity
50
26
-143
27
-28
Total Liabilities & Equity
58
35
72
90
30
Shares Outstanding
40
40
40
41
42
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
3
3
6
3
2
Net Debt
-52
-29
10
-78
-18
Net Debt to Equity
-103.26
-109.71
-6.67
-292.5
64.17
Tangible Common Equity Ratio
-70.95
-230.71
-197.73
29.63
-91.63
Current Ratio
9.34
3.87
2.78
5.06
1.48
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-28
-41
-61
-87
-60
+ Depreciation & Amortization
- -
1
2
3
3
+ Non-Cash Items
1
1
9
8
9
+ Stock-Based Compensation
- -
- -
- -
2
4
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
1
1
9
6
5
+ Chg in Non-Cash Work Cap
- -
1
45
-5
-12
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
- -
-1
1
-3
+ Inc (Dec) in Accts Payable
2
2
4
-1
-2
+ Inc (Dec) in Other
-1
-1
43
-6
-7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-27
-37
-5
-81
-60
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-2
-5
-1
- -
+ Acq of Fixed Prod Assets
- -
-2
-5
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
31
2
+ Increase in Capital Stock
- -
- -
- -
31
2
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-28
74
- -
+ Dec in LT Investment
- -
- -
63
108
- -
+ Inc in LT Investment
- -
- -
-91
-34
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-2
-33
72
- -
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
34
-1
-1
+ Cash From Debt
- -
- -
35
- -
- -
+ Repayments of Debt
- -
- -
-1
-1
-1
+ Other Financing Activities
72
16
-1
32
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
72
16
33
62
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
45
-23
-4
53
-60
EBITDA
-28
-40
-54
-86
-59
EBITDA Margin (%)
- -
- -
-551.85
-575.74
-299.64
Free Cash Flow
-27
-39
-10
-82
-60
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-23
-83
-84
-61
Free Cash Flow per Basic Share
-0.68
-0.97
-0.24
-2.46
-1.45
Price/Free Cash Flow
-40.9
-18.51
-1,076.11
-1.23
-0.29
Cash Flow to Net Income
0.95
0.92
0.08
0.93
0.99
Capital Expenditures
- -
-2
-5
-1
- -